Transforming growth factor β suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene

被引:100
作者
Li, He
Xu, Dakang
Li, Jinhua
Berndt, Michael C.
Liu, Jun-Ping
机构
[1] Monash Univ, Dept Immunol, Melbourne, Vic 3181, Australia
[2] Monash Univ, Monash Inst Med Res, Melbourne, Vic 3181, Australia
关键词
D O I
10.1074/jbc.M602381200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Telomerase underpins stem cell renewal and proliferation and is required for most neoplasia. Recent studies suggest that hormones and growth factors play physiological roles in regulating telomerase activity. In this report we show a rapid repression of the telomerase reverse transcriptase ( TERT) gene by transforming growth factor beta(TGF-beta) in normal and neoplastic cells by a mechanism depending on the intracellular signaling protein Smad3. In human breast cancer cells TGF-beta induces rapid entry of Smad3 into the nucleus where it binds to the TERT gene promoter and represses TERT gene transcription. Silencing Smad3 gene expression or genetically deleting the Smad3 gene disrupts TGF-beta repression of TERT gene expression. Expression of the Smad3 antagonist, Smad7, also interrupts TGF-beta-mediated Smad3-induced repression of the TERT gene. Mutational analysis identified the Smad3 site on the TERT gene promoter, mediating TERT repression. In response to TGF-beta, Smad3 binds to c-Myc; knocking down c-Myc, Smad3 does not bind to the TERT gene, suggesting that c-Myc recruits Smad3 to the TERT promoter. Thus, TGF-beta negatively regulates telomerase activity via Smad3 interactions with c-Myc and the TERT gene promoter. Modifying the interaction between Smad3 and TERT gene may, thus, lead to novel strategies to regulate telomerase.
引用
收藏
页码:25588 / 25600
页数:13
相关论文
共 67 条
  • [1] Transcriptional regulation and transformation by MYC proteins
    Adhikary, S
    Eilers, M
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (08) : 635 - 645
  • [2] Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage
    Armstrong, L
    Saretzki, G
    Peters, H
    Wappler, I
    Evans, J
    Hole, N
    von Zglinicki, T
    Lako, M
    [J]. STEM CELLS, 2005, 23 (04) : 516 - 529
  • [3] Ashcroft M, 1999, MOL CELL BIOL, V19, P1751
  • [4] Telomeres and telomerase: their mechanisms of action and the effects of altering their functions
    Blackburn, EH
    [J]. FEBS LETTERS, 2005, 579 (04): : 859 - 862
  • [5] Telomeres and human disease: Ageing, cancer and beyond
    Blasco, MA
    [J]. NATURE REVIEWS GENETICS, 2005, 6 (08) : 611 - 622
  • [6] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [7] Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells
    Budiyanto, A
    Bito, T
    Kunisada, M
    Ashida, M
    Ichihashi, M
    Ueda, M
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (05) : 1088 - 1094
  • [8] Cerezo A, 2002, J CELL SCI, V115, P1305
  • [9] Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops
    Cesare, AJ
    Griffith, JD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (22) : 9948 - 9957
  • [10] E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression
    Chen, CR
    Kang, YB
    Siegel, PM
    Massagué, J
    [J]. CELL, 2002, 110 (01) : 19 - 32